{
  "trial_id": "NCT00257920",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration on hemodialysis, postmenopausal status, surgical sterility status, method of birth control, breastfeeding status, serum pregnancy test result, intact PTH value, serum calcium level, serum phosphorus level, CaxP product, history of allergic reaction to vitamin D, presence of chronic gastrointestinal disease, liver enzyme levels (SGOT/AST, SGPT/ALT), hemoglobin level, use of maintenance calcitonin, use of Sensipar\u00ae (cinacalcet), use of glucocorticoids, use of drugs affecting calcium or bone metabolism, use of estrogen and/or progestin therapy, receipt of any investigational drug.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Calcium Absorption Fraction",
          "Calcium Absorption Fractions Analyzed by Analysis of Variance (ANOVA)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration on hemodialysis",
        "postmenopausal status",
        "surgical sterility status",
        "method of birth control",
        "breastfeeding status",
        "serum pregnancy test result",
        "intact PTH value",
        "serum calcium level",
        "serum phosphorus level",
        "CaxP product",
        "history of allergic reaction to vitamin D",
        "presence of chronic gastrointestinal disease",
        "liver enzyme levels (SGOT/AST, SGPT/ALT)",
        "hemoglobin level",
        "use of maintenance calcitonin",
        "use of Sensipar\u00ae (cinacalcet)",
        "use of glucocorticoids",
        "use of drugs affecting calcium or bone metabolism",
        "use of estrogen and/or progestin therapy",
        "receipt of any investigational drug."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Duration on Hemodialysis, Intact Parathyroid Hormone (PTH) Levels, Serum Calcium Levels, Serum Phosphorus Levels, CaxP Product, Hemoglobin Levels, Liver Enzyme Levels (SGOT/AST, SGPT/ALT),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Calcium Absorption Fraction",
          "Calcium Absorption Fraction"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Duration on Hemodialysis",
        "Intact Parathyroid Hormone (PTH) Levels",
        "Serum Calcium Levels",
        "Serum Phosphorus Levels",
        "CaxP Product",
        "Hemoglobin Levels",
        "Liver Enzyme Levels (SGOT/AST, SGPT/ALT)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Hemodialysis duration, Intact PTH value, Serum calcium level, Serum phosphorus level, CaxP product,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Calcium Absorption Fraction"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Hemodialysis duration",
        "Intact PTH value",
        "Serum calcium level",
        "Serum phosphorus level",
        "CaxP product"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of chronic kidney disease, duration of hemodialysis, intact PTH value, serum calcium level, serum phosphorus level, CaxP product, hemoglobin level, liver enzyme levels, history of allergic reactions, history of gastrointestinal disease, use of medications affecting calcium or bone metabolism, estrogen and/or progestin therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Calcium Absorption Fraction",
          "Calcium Absorption Fractions Analyzed by Analysis of Variance (ANOVA)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of chronic kidney disease",
        "duration of hemodialysis",
        "intact PTH value",
        "serum calcium level",
        "serum phosphorus level",
        "CaxP product",
        "hemoglobin level",
        "liver enzyme levels",
        "history of allergic reactions",
        "history of gastrointestinal disease",
        "use of medications affecting calcium or bone metabolism",
        "estrogen and/or progestin therapy."
      ]
    }
  }
}